Physician profile
Philip Vendittelli
NPI 1871949925
$7,392.29
in general payments reported to CMS, 2019-2025
34 companies · $1,400 in 2025
The $1,400 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $119 · 2020: $152 · 2021: $1,505 · 2022: $1,513 · 2023: $1,543 · 2024: $1,159 · 2025: $1,400.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,103.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,102.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,367.86 | 2021-2025 | Optis, Pressurewire, Thoratec Heartmate 3 Lvas Implant Kit |
| Inari Medical, INC. | $647.72 | 2023-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $599.93 | 2021-2025 | Lifevest |
| Amgen INC. | $549.87 | 2021-2025 | Repatha, Repatha |
| Boston Scientific Corporation | $438.01 | 2022-2025 | Watchman Flx, General - Balloon Catheters, Lux-Dx Insertable Cardiac Monitor |
| Boehringer Ingelheim Pharmaceuticals, INC. | $407.09 | 2021-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $386.01 | 2019-2024 | Xarelto |
| Kestra Medical Technology Services, INC. | $360.27 | 2024-2025 | Assure Wcd |
| Astrazeneca Pharmaceuticals LP | $292.50 | 2020-2025 | Wainua |
| Cardiva Medical, INC. | $280.78 | 2022-2023 | Cardiva Vascade 6/7f Vcs |
| Shockwave Medical, INC | $269.67 | 2022-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Esperion Therapeutics, INC. | $239.58 | 2021 | |
| Pfizer INC. | $165.96 | 2024-2025 | |
| Terumo Medical Corporation | $162.02 | 2022-2023 | Glidesheath Slender, Azur Cx Detachable |
| Chiesi USA, INC. | $152.52 | 2023-2025 | Kengreal, Cleviprex |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $146.41 | 2023 | Indigo System |
| Teleflex LLC | $111.19 | 2022-2025 | Turnpike, Guideliner |
| Truvic Medical, INC. | $100.00 | 2022 | |
| Cardiovascular Systems INC. | $98.27 | 2022 | |
| Novartis Pharmaceuticals Corporation | $87.72 | 2023-2025 | |
| Cardinal Health 200 LLC | $74.34 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $68.18 | 2024-2025 | Camzyos, Eliquis |
| Merck Sharp & Dohme LLC | $64.68 | 2024-2025 | Verquvo |
| Kiniksa Pharmaceuticals International, Plc | $60.63 | 2024 | Arcalyst |
| Scpharmaceuticals INC. | $41.29 | 2025 | |
| Philips North America LLC | $36.86 | 2023-2024 | (5044) Mcot |
| Cathworks, INC. | $36.15 | 2023 | Ffrangio |
| Abiomed | $31.78 | 2025 | |
| Stryker Corporation | $26.28 | 2025 | Flowtriever |
| Angiodynamics, INC. | $24.12 | 2022 | |
| Glaxosmithkline, LLC. | $20.57 | 2025 | Arexvy, Shingrix |
| Cordis US Corp. | $17.86 | 2023 | Zephyr |
| Edwards Lifesciences Corporation | $13.71 | 2023 | Sapien 3 Ultra Resilia |
| Getinge USA Sales, LLC | $12.46 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Vendittelli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.